Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

NCT01413893 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT01413893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01413893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2011
Completion date
June 30, 2012
Enrollment
35 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors